192 related articles for article (PubMed ID: 1515249)
1. CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancer.
Hamazoe R; Maeta M; Matsui T; Shibata S; Shiota S; Kaibara N
Eur J Cancer; 1992; 28A(8-9):1351-4. PubMed ID: 1515249
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies.
Kornek GV; Depisch D; Rosen HR; Temsch EM; Scheithauer W
J Cancer Res Clin Oncol; 1992; 118(4):318-20. PubMed ID: 1374412
[TBL] [Abstract][Full Text] [Related]
3. CA72-4: a new tumour marker for gastric cancer.
Byrne DJ; Browning MC; Cuschieri A
Br J Surg; 1990 Sep; 77(9):1010-3. PubMed ID: 2207563
[TBL] [Abstract][Full Text] [Related]
4. CA72-4 antigen levels in serum and peritoneal washing in gastric cancer. Correlation with morphological aspects of neoplasia.
Fernandes LL; Martins LC; Nagashima CA; Nagae AC; Waisberg DR; Waisberg J
Arq Gastroenterol; 2007; 44(3):235-9. PubMed ID: 18060278
[TBL] [Abstract][Full Text] [Related]
5. CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma.
Yamamoto M; Yoshinaga K; Matsuyama A; Tsutsui S; Ishida T
J Cancer Res Clin Oncol; 2014 Apr; 140(4):607-12. PubMed ID: 24509654
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Serum CA72-4 and CEA Levels in Patient with Endoscopically Suspected Gastric Carcinoma.
Rehena Z; Ghosh CK; Afroz F; Alam MB; Ferdousi S; Mahmuduzzaman M; Sultana T; Ahmed AN
Mymensingh Med J; 2015 Jul; 24(3):542-9. PubMed ID: 26329953
[TBL] [Abstract][Full Text] [Related]
9. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
[TBL] [Abstract][Full Text] [Related]
10. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
11. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
12. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
Takahashi Y; Mai M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
[TBL] [Abstract][Full Text] [Related]
13. Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9.
Filella X; Molina R; Mengual PJ; Jo J; Ballesta AM
J Nucl Biol Med (1991); 1991; 35(3):158-61. PubMed ID: 1816871
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.
Li Y; Yang Y; Lu M; Shen L
Hepatogastroenterology; 2011; 58(112):2166-70. PubMed ID: 22024091
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma.
Ikeguchi M; Katano K; Saitou H; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1997; 44(15):866-71. PubMed ID: 9222706
[TBL] [Abstract][Full Text] [Related]
17. [CA72-4 and CEA in serum and peritoneal washing in gastric cancer].
Mandorwski S; Lourenço LG; Forones NM
Arq Gastroenterol; 2002; 39(1):17-21. PubMed ID: 12184160
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
19. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
Chen C; Chen Q; Zhao Q; Liu M; Guo J
Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen in gastric cancer patients.
Shimizu N; Wakatsuki T; Murakami A; Yoshioka H; Hamazoe R; Kanayama H; Maeta M; Koga S
Oncology; 1987; 44(4):240-4. PubMed ID: 3614814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]